NCT03213340

Brief Summary

This is a random order cross over design trial to evaluate the efficacy of select nutritional ingredients on enhancing muscle perfusion in response to an acute meal stimulus.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 11, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

September 14, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 2, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 2, 2019

Completed
Last Updated

January 31, 2020

Status Verified

January 1, 2020

Enrollment Period

2 years

First QC Date

June 26, 2017

Last Update Submit

January 29, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • muscle microvascular blood flow

    contrast enhanced ultrasound

    Baseline to 240 minutes

Secondary Outcomes (4)

  • muscle macrovascular blood flow

    Baseline to 240 minutes

  • central vascular blood flow

    Baseline to 90 minutes

  • cerebral blood flow

    Baseline to 120 minutes

  • endothelial function

    Baseline to 120 minutes

Study Arms (3)

Catechin Cohort 1

EXPERIMENTAL

2 treatment - Experimental Catechin Blend; Control 1 Placebo

Other: Catechin Cohort 1

Curcuminoid Cohort 2

EXPERIMENTAL

2 treatment - Experimental Curcuminoid Blend; Control 1 Placebo

Other: Curcuminoid Cohort 2

Flavonoid Cohort 3

EXPERIMENTAL

2 treatment - Experimental Flavonoid Blend; Control 2 Low-Flavonoid Blend

Other: Flavonoid Cohort 3

Interventions

\- 4 capsules taken with water 1 hour prior to meal

Catechin Cohort 1

\- 2 capsules taken with water 1 hour prior to meal

Curcuminoid Cohort 2

\- \~ 1 oz. serving consumed 30 minutes before meal

Flavonoid Cohort 3

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Body mass index (BMI) 18-30 kg/m2
  • Free from active metabolic disease
  • Normotensive

You may not qualify if:

  • Habitual gym use or formal exercise (more than once a week) or other routine strenuous physical activity
  • Smokers
  • Surgery within past 3 months
  • Active cardiovascular disease
  • Taking beta-adrenergic blocking agents
  • Cerebrovascular disease:
  • Active respiratory disease
  • Active metabolic disease
  • Active inflammatory bowel or renal disease
  • Active Malignancy or until confirmed remission
  • Clotting dysfunction
  • History of DVT
  • Significant musculoskeletal or neurological disorders
  • Family history of early (\<55y) death from cardiovascular disease
  • Known sensitivity to Sonovue contrast agent
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Nottingham

Derby, DE22 3DT, United Kingdom

Location

Study Officials

  • Suzette Pereira, PhD

    Abbott Nutrition

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: 3 cohorts, crossover within cohort
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2017

First Posted

July 11, 2017

Study Start

September 14, 2017

Primary Completion

October 2, 2019

Study Completion

October 2, 2019

Last Updated

January 31, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations